Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guang Han

Showing results (641-650 of 645) with videos related to

Pageof 65
Sort By:
You have reached the last page of results.This site can display upto 645 results.
Theranostics|January 2, 2015
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferonFeng-Qin Hou, Liu-Wei Song, Quan Yuan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled TrialYang-Si Li, Qitao Yu, Qing Bu, et al.
Nature Communications|August 14, 2025
Spin excitations and flat electronic bands in a Cr-based kagome superconductorZehao Wang, Yucheng Guo, Hsiao-Yu Huang, et al.
Signal Transduction and Targeted Therapy|September 9, 2025
Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancersGui-Zhen Wang, Zheng Wang, Shi-Hao Bai, et al.
Plos Biology|April 23, 2004
Integrative annotation of 21,037 human genes validated by full-length cDNA clonesTadashi Imanishi, Takeshi Itoh, Yutaka Suzuki, et al.
Pageof 65

Showing results (641-650 of 645) with videos related to

Sort By:
Pageof 65
You have reached the last page of results.This site can display upto 645 results.
Theranostics|January 2, 2015
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferonFeng-Qin Hou, Liu-Wei Song, Quan Yuan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled TrialYang-Si Li, Qitao Yu, Qing Bu, et al.
Nature Communications|August 14, 2025
Spin excitations and flat electronic bands in a Cr-based kagome superconductorZehao Wang, Yucheng Guo, Hsiao-Yu Huang, et al.
Signal Transduction and Targeted Therapy|September 9, 2025
Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancersGui-Zhen Wang, Zheng Wang, Shi-Hao Bai, et al.
Plos Biology|April 23, 2004
Integrative annotation of 21,037 human genes validated by full-length cDNA clonesTadashi Imanishi, Takeshi Itoh, Yutaka Suzuki, et al.
Pageof 65